RNU6-143P

Across TCGA pan-cancer cohorts, RNU6-143P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-143P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU6-143P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-143P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

PAAD, LIHC, and UCS are the cancer types where RNU6-143P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.098	0.505	.003	72	view →
LIHC	DFS	Tertile	All	0.088	0.557	<.001	42	view →
UCS	DFS	Tertile	III,IV	0.120	0.441	.004	36	view →
THYM	OS	Tertile	All	0.186	0.930	.003	24	view →
KIRP	DFS	Tertile	III,IV	0.040	0.691	<.001	18	view →
ESCA	OS	Tertile	III,IV	0.877	0.364	.012	18	view →
SARC	DFS	Tertile	All	0.247	0.605	.013	18	view →
BLCA	OS	Tertile	IV	0.195	0.484	.039	9	view →
CHOL	DFS	Tertile	All	0.118	0.495	.044	9	view →
SKCM	DFS	Tertile	All	0.435	0.775	<.001	9	view →
BRCA	DFS	Tertile	III,IV	1.000	0.458	.042	6	view →
KIRC	DFS	Tertile	All	0.331	0.653	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-143P–PAAD (DFS)

Open the PAAD breakdown →